Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Stock Option Valuation Assumptions) (Details)

v3.22.1
Stock-Based Compensation and Other Benefit Plans (Stock Option Valuation Assumptions) (Details) - $ / shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Valuation of the options granted    
Weighted average exercise price - ($/share) $ 6.41 $ 3.14
Expected life in years 6 years 6 years
Average expected volatility 72.00% 75.00%
Risk-free interest rate 1.98% 0.95%
Expected dividend yield 2.30%  
Weighted average grant date fair value - ($/share) $ 2.84 $ 2.07